DDAVP Nasal Spray
OVERDOSE
Signs of overdose may include confusion, drowsiness, continuing headache, problems with passing urine and rapid weight gain due to fluid retention. (See WARNINGS.) In case of overdosage, the dose should be reduced, frequency of administration decreased, or the drug withdrawn according to the severity of the condition. There is no known specific antidote for desmopressin acetate or DDAVP Nasal Spray.
An oral LD50 has not been established. An intravenous dose of 2 mg/kg in mice demonstrated no effect.
CONTRAINDICATIONS
DDAVP Nasal Spray is contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of DDAVP Nasal Spray.
DDAVP is contraindicated in patients with moderate to severe renal impairment (defined as a creatinine clearance below 50ml/min).
DDAVP is contraindicated in patients with hyponatremia or a history of hyponatremia.
Generic Name: Desmopressin Acetate Nasal Spray
« Previous: DDAVP Nasal Spray - Warnings & Precautions
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Health Extras
Sickle Cell Miracle
We follow one young man with sickle cell, as he juggles a treatment regimen that is allowing him to plan for the future.See more WebMD Videos »
DDAVP Nasal Spray
New & Updated
Slideshows
Updated & New
RxList does not provide medical advice, diagnosis or treatment.